Eric Cox

What is he best known for?

The fields of study he is best known for:

• Immune system
• Internal medicine
• Gene

His primary areas of investigation include Microbiology, Immune system, Enterotoxigenic Escherichia coli, Immunology and Antibody. His Microbiology research incorporates themes from Small intestine, Virology, Chlamydia psittaci, Escherichia coli and Chlamydiaceae. His Immune system research is multidisciplinary, incorporating perspectives in Inflammation, Heat-labile enterotoxin and Antigen.

His Enterotoxigenic Escherichia coli research includes themes of Oral administration, Fimbria, Feces and Diarrhea. His Immunology research is multidisciplinary, relying on both Osteoarthritis and Intestinal mucosa. In his study, Glucan is strongly linked to In vivo, which falls under the umbrella field of Antibody.

His most cited work include:

• Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. (419 citations)
• The IgA system: a comparison of structure and function in different species. (145 citations)
• Receptor-Dependent Immune Responses in Pigs after Oral Immunization with F4 Fimbriae (128 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Microbiology, Immunology, Immune system, Virology and Enterotoxigenic Escherichia coli. Eric Cox has researched Microbiology in several fields, including Fimbria, Bacterial adhesin, Escherichia coli, Vaccination and Antibody. The concepts of his Fimbria study are interwoven with issues in Receptor, Intestinal mucosa, Intestinal epithelium and Immunogenicity.

His research in Escherichia coli intersects with topics in Lactoferrin, Feces and Bacteria. His Immune system research is multidisciplinary, incorporating elements of Peripheral blood mononuclear cell and Antigen. His Virology study combines topics in areas such as Chlamydia psittaci, DNA vaccination and Toxoplasma gondii.

He most often published in these fields:

• Microbiology (44.73%)
• Immunology (30.66%)
• Immune system (28.32%)

What were the highlights of his more recent work (between 2016-2021)?

• Microbiology (44.73%)
• Immune system (28.32%)
• Immunology (30.66%)

In recent papers he was focusing on the following fields of study:

Eric Cox spends much of his time researching Microbiology, Immune system, Immunology, Escherichia coli and Lactoferrin. His research investigates the connection between Microbiology and topics such as Enterotoxigenic Escherichia coli that intersect with problems in Intestinal epithelium. His study in Immune system is interdisciplinary in nature, drawing from both Peripheral blood mononuclear cell, Antibody, Toxoplasma gondii and Vaccination.

His studies deal with areas such as Metabolite and Metabolomics as well as Immunology. The study incorporates disciplines such as Veterinary medicine and Antibiotics, Antibiotic resistance, Bacteria in addition to Escherichia coli. While the research belongs to areas of Lactoferrin, he spends his time largely on the problem of Antimicrobial, intersecting his research to questions surrounding In vivo.

Between 2016 and 2021, his most popular works were:

• Lactoferrin inhibits E. coli O157:H7 growth and attachment to intestinal epithelial cells (30 citations)
• Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs (23 citations)
• Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection. (23 citations)

In his most recent research, the most cited papers focused on:

• Internal medicine
• Immune system
• Gene

Microbiology, Escherichia coli, Antibiotics, Immune system and Immunology are his primary areas of study. His Microbiology research includes elements of Excretion, Enterotoxigenic Escherichia coli and Intestinal epithelium. Eric Cox works mostly in the field of Enterotoxigenic Escherichia coli, limiting it down to topics relating to Yeast and, in certain cases, Antibody, as a part of the same area of interest.

His Escherichia coli study combines topics from a wide range of disciplines, such as Lactoferrin and Antibiotic resistance, Bacteria. His work on Immunity as part of general Immune system research is frequently linked to Mini review, thereby connecting diverse disciplines of science. His research on Immunology frequently connects to adjacent areas such as Placebo.